Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
29.01
+2.16 (8.04%)
At close: Dec 20, 2024, 4:00 PM
29.03
+0.02 (0.07%)
After-hours: Dec 20, 2024, 5:35 PM EST
Beam Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Beam Therapeutics stock have an average target of 47.67, with a low estimate of 24 and a high estimate of 80. The average target predicts an increase of 64.32% from the current stock price of 29.01.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BEAM stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 4 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +175.77% | Dec 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +175.77% | Nov 7, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | -17.27% | Nov 6, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $27 → $39 | Hold → Buy | Upgrades | $27 → $39 | +34.44% | Nov 6, 2024 |
| Scotiabank | Scotiabank | Hold Initiates $24 | Hold | Initiates | $24 | -17.27% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
51.86M
from 377.71M
Decreased by -86.27%
Revenue Next Year
57.47M
from 51.86M
Increased by 10.82%
EPS This Year
-4.81
from -1.72
EPS Next Year
-4.94
from -4.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 78.8M | 115.5M | 168.0M | |||
| Avg | 51.9M | 57.5M | 62.0M | |||
| Low | 37.2M | 19.6M | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -79.2% | 122.7% | 192.3% | |||
| Avg | -86.3% | 10.8% | 7.9% | |||
| Low | -90.1% | -62.2% | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -4.58 | -3.65 | -2.90 | |||
| Avg | -4.81 | -4.94 | -4.50 | |||
| Low | -4.93 | -5.76 | -5.56 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.